AU2008251520B2 — Novel solvate and crystalline forms of carbamoyl-cyclohexane derivatives
Assigned to Richter Gedeon Nyrt · Expires 2014-03-06 · 12y expired
What this patent protects
The present invention relates to novel solvate and crystalline forms of carbamoyl- cyclohexane derivatives and, more particularly, to novel solvate and crystalline forms of trans-l {4-[2-[4-(2,3-dichlorophenyl)-piperazin-l-yl]-ethyl]-cyclohexyl}-3,3-dimethyl- urea hydrochloride. …
USPTO Abstract
The present invention relates to novel solvate and crystalline forms of carbamoyl- cyclohexane derivatives and, more particularly, to novel solvate and crystalline forms of trans-l {4-[2-[4-(2,3-dichlorophenyl)-piperazin-l-yl]-ethyl]-cyclohexyl}-3,3-dimethyl- urea hydrochloride. Processes for the preparation of these forms, compositions containing these forms, and methods of use thereof are also described.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.